mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.003 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.003 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
TAK-715 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
ML320 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.004 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.006 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.007 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.008 |